Alpine salamanders at risk? The current status of an emerging fungal pathogen
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0298591 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Philipp Böning und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biogeography, Trier University, Trier, Germany. Hauptthemen laut MEDLINE: Batrachochytrium, Mycoses, Caudata. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Gesellschaft für Herpetologie und Terrarienkunde, Societas Europaea Herpetologica, Amt der Tiroler Landesregierung.
Abstract (Originalsprache)
Amphibians globally suffer from emerging infectious diseases like chytridiomycosis caused by the continuously spreading chytrid fungi. One is Batrachochytrium salamandrivorans ( Bsal ) and its disease ‒ the ‘salamander plague’ ‒ which is lethal to several caudate taxa. Recently introduced into Western Europe, long distance dispersal of Bsal , likely through human mediation, has been reported. Herein we study if Alpine salamanders ( Salamandra atra and S . lanzai ) are yet affected by the salamander plague in the wild. Members of the genus Salamandra are highly susceptible to Bsal leading to the lethal disease. Moreover, ecological modelling has shown that the Alps and Dinarides, where Alpine salamanders occur, are generally suitable for Bsal . We analysed skin swabs of 818 individuals of Alpine salamanders and syntopic amphibians at 40 sites between 2017 to 2022. Further, we compiled those with published data from 319 individuals from 13 sites concluding that Bsal infections were not detected. Our results suggest that the salamander plague so far is absent from the geographic ranges of Alpine salamanders. That means that there is still a chance to timely implement surveillance strategies. Among others, we recommend prevention measures, citizen science approaches, and ex situ conservation breeding of endemic salamandrid lineages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biogeography, Trier University, Trier, Germany.
- Department of Environmental Science and Policy, University of Milan, Milan, Italy.
- St. Michael College, Zaandam, Netherlands.
- Department of Biology, University of Padova, Padova, Italy.
- National Biodiversity Future Center, Palermo, Italy.
- Technisches Büro für Biologie, Absam, Austria.
ORCID-Profile: Philipp Böning, Camille Leroux, Raoul Manenti, Amadeus Plewnia
Förderung
- Deutsche Gesellschaft für Herpetologie und Terrarienkunde
- Societas Europaea Herpetologica
- Amt der Tiroler Landesregierung
- Inatura
- Österreichische Zoo Organisation
- Östereichische Gesellschaft für Herpetologie
- Konrad Lorenz Institute of Ethology
- Vienna Zoo
Zitieren
APA
Böning, P., Lötters, S., Barzaghi, B., Bock, M., Bok, B., Bonato, L., Ficetola, G. F., Glaser, F., Griese, J., Grabher, M., Leroux, C., Munimanda, G., Manenti, R., Ludwig, G., Preininger, D., Rödel, M. O., Seibold, S., Smith, S., Tiemann, L., …, & Plewnia, A. (2024). Alpine salamanders at risk? The current status of an emerging fungal pathogen. PLOS ONE. https://doi.org/10.1371/journal.pone.0298591
Vancouver
Böning P, Lötters S, Barzaghi B, Bock M, Bok B, Bonato L, et al. Alpine salamanders at risk? The current status of an emerging fungal pathogen. PLOS ONE. 2024. doi:10.1371/journal.pone.0298591
BibTeX
@article{Bning2024,
author = {Böning, Philipp and Lötters, Stefan and Barzaghi, Benedetta and Bock, Marvin and Bok, Bobby and Bonato, Lucio and Ficetola, Gentile Francesco and Glaser, Florian and Griese, Josline and Grabher, Markus and Leroux, Camille and Munimanda, Gopikrishna and Manenti, Raoul and Ludwig, Gerda and Preininger, Doris and Rödel, Mark-Oliver and Seibold, Sebastian and Smith, Steve and Tiemann, Laura and Thein, Jürgen and Veith, Michael and Plewnia, Amadeus},
title = {Alpine salamanders at risk? The current status of an emerging fungal pathogen},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0298591}
}
EUVIMED